Canopy Growth Reports Second Quarter Fiscal Year 2027 Financial Results; Net Revenue Growth of 22% Led by a 141% Increase in International Markets Cannabis
Canopy Growth posted Q2 FY2027 net revenue of $81.4M, up 22% year-over-year, led by 141% growth in international cannabis revenue on strong Germany and Poland medical sales. Canada medical cannabis grew 18% and adult-use grew 17%, both aided by the MTL Cannabis acquisition, while Storz & Bickel revenue fell 4%.
Key figures
- Revenue
- 81373000
- Revenue Yoy
- 22%
- Gross margin
- 29%
- Storz bickel yoy
- -4%
- Canada medical yoy
- 18%
- Gross margin prior
- 33%
- Canada adult use yoy
- 17%
- Cannabis revenue yoy
- 30%
- Cash and equivalents cad
- 247340000
- Storz bickel revenue cad
- 15138000
- International revenue yoy
- 141%
- Canada medical revenue cad
- 25840000
- Canada adult use revenue cad
- 28127000
- Cannabis segment revenue cad
- 66235000
- Canopy usa fair value charges cad
- 35800000
- International cannabis revenue cad
- 12268000
AI analysis
Red flags5 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.